Companies

Dynavax Technologies Corp

NASDAQ: DVAX
$15.50
▲ $0.00 (+0.00%) today
Markets closed · 1:27am ET

DVAX Coverage

Page 3
11:13am ET
Investing

Today’s Market Winners and Losers

The stock market is mixed Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq up 0.17% and the S&P 500 down 0.01%. Today’s winners are an online gaming firm that may…

247sam
8:48am ET
Health and Healthcare

Death for Dynavax’s Lead Drug Candidate

ThinkstockDynavax Technologies Corp. (NASDAQ: DVAX) is feeling the wrath of the markets after an FDA panel said that there was insufficient data to support its investigational Hepatitis B drug called Hepislav. The…

Jon C. Ogg
9:24am ET
Health and Healthcare

Biotech Implosion: Dynavax (DVAX)

Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today.  The company gave an update on an FDA clinical hold on its investigational vaccine HEPLISAV…

Douglas A. McIntyre